AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31945659
Drug: Infiltration anaesthesia
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration anaesthesia (IA) with 0.2% ropivacaine (RPV) and FNT 50 μg
Trial: 31945659
Drug: Infiltration anaesthesia
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration anaesthesia (IA) with 0.2% bupivacaine (BPV) and FNT 50 μg
Trial: 25711974
Drug: Automated, telephone‐based,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated, telephone‐based, interactive voice response (IVR) intervention, called twice weekly
Trial: 21485398
Drug: non-immersion control
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: non-immersion control with no drug
Trial: 19751000
Drug: All-polyethylene step-cut
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All-polyethylene step-cut implants
Trial: 19751000
Drug: Metal-backed nonmodular
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metal-backed nonmodular fixed-bearing implants
Trial: 19751000
Drug: Modular fixed-bearing
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Modular fixed-bearing implants
Trial: 16981140
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol plus MPA
Trial: 15287931
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times daily plus a mildly reduced-calorie diet
Trial: 21248612
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid modified‐immediate‐release (MIR) 1.3 g (2 650‐mg tablets)
Trial: 21248612
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid delayed‐release (DR) 1.3 g (2 650‐mg tablets)
Trial: 21248612
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid MIR 1.3 g dosed every 8 hours for 5 days
Trial: 21248612
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid DR 1.3 g
Trial: 20337841
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality treatment (Induction Chemotherapy and Chemoradiation)
Trial: 15188756
Drug: Trimetazidine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (60 mg/kg)
Trial: 22316839
Drug: School based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School based exercise program (twice a week for six weeks, 50 minutes per session)
Trial: 11277962
Drug: Desloratadine 5
RxNorm normalized name: desloratadine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 5 mg once daily for 6 weeks
Trial: 9252849
Drug: 1,25-dihydroxyvitamin D
RxNorm normalized name: 1,25-dihydroxyvitamin D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-dihydroxyvitamin D (0.5 microgram twice a day for 5 days) + calcium carbonate (1,500 mg/day) + carbocalcitonin (40 UMRC intramuscularly three times weekly)
Trial: 8503418
Drug: Subcutaneous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous recombinant human erythropoietin (Epo)
Trial: 8503418
Drug: Intravenous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous recombinant human erythropoietin (Epo)
Trial: 28490515
Drug: Iron (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron (60 mg)
Trial: 17509587
Drug: Transdermal E(2)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal E(2) therapy (100 microg/d)
Trial: 16865142
Drug: 20% citric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% citric acid solution and photo‐activated disinfection
Trial: 16865142
Drug: 20% citric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% citric acid and 2.25% sodium hypochlorite solutions
Trial: 12789897
Drug: Community Treatment
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL LIQUID [Sanitizing Liquid for Community Support]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community Treatment Program
Trial: 7934682
Drug: Atropine 8
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine 8 micrograms/kg and edrophonium 0.75 mg/kg
Trial: 29216361
Drug: OBE2109 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OBE2109 100 mg
Trial: 29216361
Drug: OBE2109 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OBE2109 200 mg
Trial: 29216361
Drug: OBE2109 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OBE2109 100 mg/1.0 mg/0.5 mg (add-back therapy)
Trial: 29216361
Drug: OBE2109 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OBE2109 200 mg (with E2/NETA)
Trial: 18301060
Drug: Viral suppression
RxNorm normalized name: Buckley's Cough Suppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral suppression (by > 1.0 log10 copies/ml or to < 400 copies/ml)
Trial: 12185552
Drug: Sumatriptan 3
RxNorm normalized name: SUMATRIPTAN 3MG/0.5ML INJ PEN 0.5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 3 mg
Trial: 7133973
Drug: pirprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pirprofen (600 mg/day)
Trial: 29017796
Drug: Collagen tripeptide
RxNorm normalized name: tripeptide-29
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen tripeptide (CTP) 3.9g daily for 12 weeks
Trial: 17341247
Drug: 0.25 mg/d
RxNorm normalized name: fluoride 0.25 mg/drop oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/d of micronized 17beta-estradiol (estrogen therapy, n=32)
Trial: 11153533
Drug: Amlodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (10 mg daily for 2 weeks)
Trial: 3342289
Drug: New tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New tablet formulation of carbocysteine
Trial: 3342289
Drug: Syrup containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup containing carbocysteine
Trial: 3342289
Drug: Capsules containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules containing carbocysteine
Trial: 30048223
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL irrigation volume
Trial: 30048223
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL irrigation volume
Trial: 30048223
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between 50 mL and 200 mL irrigation volumes
Trial: 21683750
Drug: EmulGold(®) (EG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EmulGold(®) (EG) at doses of 40 g
Trial: 21683750
Drug: PreVitae(®) (PV)
RxNorm normalized name: Brevital
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PreVitae(®) (PV) at doses of 40 g
Trial: 21683750
Drug: EmulGold(®) (EG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EmulGold(®) (EG) at doses of 10 or 20 g
Trial: 21683750
Drug: EmulGold(®) (EG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EmulGold(®) (EG) at doses of 5 and 10 g
Trial: 21683750
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of both gums compared to negative control
Trial: 21683750
Drug: Negative control
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control (250 ml of water)
Trial: 16550734
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg once daily + clarithromycin 500 mg b.i.d. + amoxicillin 1 g b.i.d. for 7 days
Trial: 16550734
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg b.i.d. + clarithromycin 500 mg b.i.d. + amoxicillin 1 g b.i.d. for 7 days
Trial: 16550734
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg once daily with clarithromycin 500 mg b.i.d. for 1 week
Trial: 11145281
Drug: PPI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI treatment (30 mg lansoprazole/day for 8 weeks followed by 15 or 30 mg lansoprazole or 20 mg omeprazole/day for 12 months)
Trial: 2000109
Drug: Surfactant as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant as prophylaxis (90 mg intratracheal dose at delivery)
Trial: 2000109
Drug: Surfactant as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant as rescue therapy (90 mg intratracheal dose several hours after delivery if criteria met)
Trial: 2000109
Drug: Surfactant as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant as rescue therapy (for infants ≤ 26 weeks' gestation)
Trial: 24401940
Drug: Maxalt (10‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxalt (10‐mg rizatriptan)
Trial: 20443650
Drug: Olopatadine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olopatadine 5 mg
Trial: 20443650
Drug: Olopatadine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olopatadine 2.5 mg
Trial: 17588581
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (other antihypertensive treatment)
Trial: 16805936
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg kg‐1 h‐1
Trial: 10690672
Drug: Diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50 mg rectally 3 times during the first 24 hours postoperatively
Trial: 9374256
Drug: Heparin-coated IOLs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated IOLs
Trial: 8263310
Drug: d-fenfluramine and
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-fenfluramine and d-amphetamine combination
Trial: 3834831
Drug: Rimantadine hydrochloride
RxNorm normalized name: Rimantadine Hydrochloride
DrugBank: Rimantadine (DB00478)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rimantadine hydrochloride (200 mg single dose)
Trial: 3834831
Drug: Amantadine hydrochloride
RxNorm normalized name: Amantadine Hydrochloride
DrugBank: Amantadine (DB00915)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amantadine hydrochloride (200 mg single dose)
Trial: 24774470
Drug: Tailor‐made weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailor‐made weight loss intervention and oral glucosamine sulfate
Trial: 19926502
Drug: Prednisone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (25 mg daily for 15 days, then 12.5 mg daily for 15 days, then 6.25 mg daily for 15 days, then 6.25 mg on alternate days for 15 days)
Trial: 19926502
Drug: Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (10 mg daily for the first month, then on alternate days for the second month)
Trial: 19926502
Drug: Placebo (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100 mg cellulose daily for the first month, then on alternate days for the second month)
Trial: 19061737
Drug: Low-frequency electric
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency electric muscle stimulation combined with conventional physical therapy (n=16; 78±8 y)
Trial: 19061737
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy alone (n=13; 76±10 y)
Trial: 8676836
Drug: Lactobacillus acidophilus
RxNorm normalized name: Lactobacillus acidophilus
DrugBank: Lactobacillus acidophilus (DB15823)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus acidophilus (LBA) treatment
Trial: 4003917
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) aerosol, 4 inhalations twice a day (b.i.d.), total dose 336 micrograms/day for 8 weeks
Trial: 4003917
Drug: Placebo aerosol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo aerosol, 4 inhalations twice a day (b.i.d.) for 8 weeks
Trial: 4003917
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) aerosol, 2 inhalations 4 times a day (q.i.d.), total dose 336 micrograms/day for 2 weeks
Trial: 20373168
Drug: Family medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family medicine clerkship with a 3-hour workshop on clinical reasoning using illness scripts.
Trial: 15034161
Drug: Ketoconazole 100
RxNorm normalized name: ketoconazole 100 % MISCELL CRYSTALS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 100 mg/day in addition to tacrolimus
Trial: 7614594
Drug: dietetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dietetic therapy of chinese herb rhizome wheat starch
Trial: 3277325
Drug: Definitive radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Definitive radiation therapy with additional cyclophosphamide (Cytoxan) or estramustine phosphate (Emcyt) chemotherapy for 2 years
Trial: 3277325
Drug: Definitive radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Definitive radiation therapy only
Trial: 22899947
Drug: Transamidated gluten
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transamidated gluten (3.7 g/day)
Trial: 19865058
Drug: EPO (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPO (subcutaneous 2000 microg three times weekly) plus parenteral iron
Trial: 19865058
Drug: Parenteral iron
RxNorm normalized name: Iron, parenteral preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral iron only
Trial: 9529266
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens therapy at 0.625 mg daily
Trial: 2388978
Drug: Dextrose tablets
RxNorm normalized name: Dextrose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose tablets
Trial: 2388978
Drug: Sorbitol tablets
RxNorm normalized name: Sorbitol
DrugBank: Sorbitol (DB01638)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sorbitol tablets (control)
Trial: 832943
Drug: Undecylenic acid
RxNorm normalized name: Undecylenic Acid
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Undecylenic acid powder preparations
Trial: 31820289
Drug: Ibudilast (IBUD)
RxNorm normalized name: ibudilast
DrugBank: Ibudilast (DB05266)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Ibudilast (IBUD) 50 mg twice daily for 12 weeks
Trial: 28658112
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg propofol (LPE group)
Trial: 28658112
Drug: 0.50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 mg/kg propofol (MPE group)
Trial: 28658112
Drug: 0.75 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg/kg propofol (HPE group)
Trial: 28658112
Drug: 1 to
RxNorm normalized name: Cep-11981 tosylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 to 2 mg/kg propofol (P group)
Trial: 28658112
Drug: 0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/kg propofol (E group)
Trial: 21368386
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 2 mg/d
Trial: 21368386
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 10 mg/d
Trial: 19267739
Drug: Chemotherapy at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy at a community hospital
Trial: 19267739
Drug: Chemotherapy at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy at a cancer centre
Trial: 3345643
Drug: Sucralfate (1-g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1-g tablet, four times a day for two days before and after theophylline dose)
Trial: 3345643
Drug: Non-sustained-release theophylline
RxNorm normalized name: theophylline Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-sustained-release theophylline (5-mg/kg dose)
Trial: 25966723
Drug: SRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP plus metronidazole and amoxicillin (M+A group)
Trial: 23149171
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D deficiency defined as 25(OH)D level <20 ng/mL
Trial: 15201620
Drug: Lipid-lowering therapy
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-lowering therapy with LDL-c level < 100 mg/dl
Trial: 15201620
Drug: Lipid-lowering therapy
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-lowering therapy with LDL-c level > 100 mg/dl
Trial: 8042971
Drug: Treatment (comprehensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (comprehensive relapse prevention program)
Trial: 3076905
Drug: Amitriptyline (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (median dose 125 mg)
Trial: 21732834
Drug: Isoniazid (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid (10 to 20 mg per kilogram of body weight per day)
Trial: 1577361
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg haloperidol/day for 14 days
Trial: 1577361
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg haloperidol/day for 14 days
Trial: 3453428
Drug: Individually adapted
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually adapted haloperidol dose for 14 days
Trial: 3453428
Drug: Standardized treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized treatment (10 mg or 20 mg haloperidol)
Trial: 31605794
Drug: Pembrolizumab (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab (100 to 200 mg every 3 weeks for up to 16 cycles)
Trial: 26062091
Drug: Conventional drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drop of fluorescein solution (20 mg/mL) administered to the right eye
Trial: 26062091
Drug: Ocular mist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ocular mist (10 μL) of fluorescein solution (20 mg/mL) applied to the left eye
Trial: 12826988
Drug: Diphenhydramine 75
RxNorm normalized name: diphenhydramine 18.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 75 mg
Trial: 11182260
Drug: PharmChek sweat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PharmChek sweat patch
Trial: 7942084
Drug: Gonadotropin releasing
RxNorm normalized name: Gonadotropin releasing factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotropin releasing hormone analog plus gonadotropins (group B)
Trial: 7942084
Drug: Gonadotropins only
RxNorm normalized name: Chorionic Gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotropins only (group A) with low progesterone levels (< or = 1 ng/ml)
Trial: 3061183
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg b.i.d. over 4-8 weeks
Trial: 25488826
Drug: Low 25(OH)D
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low 25(OH)D metabolism score
Trial: 17021422
Drug: Milk (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk (300 ml)
Trial: 8106650
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg once daily for 6 weeks)
Trial: 8106650
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg once daily for 6 weeks)
Trial: 3492156
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of propofol at 54 micrograms X kg‐1 X min‐1 (group 1)
Trial: 3492156
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of propofol at 108 micrograms X kg‐1 X min‐1 (group 2)
Trial: 19134170
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and counselling arms split into two groups to explore different treatment regimens
Trial: 11369685
Drug: Short oral
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short oral anticoagulant course (3 months for P-DVT/PE; 6 weeks for C-DVT)